Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Mora-Ochomogo M, Lohans CT (2021) -Lactam antibiotic targets and resistance mechanisms: From covalent inhibitors to substrates
Despite this growing list, many of these compounds are primarily in vitro substrates with little evidence supporting the in vivo regulation of their activity by DPP-4 [17]
Forecasting Methods Time-series modelling S-curve and diffusion models (for emerging technologies) Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes) Price elasticity models Market maturity and lifecycle-based projections Scenario Analysis Given inherent uncertainties, three scenarios were constructed: Base-Case Scenario: Expected trajectory under current conditions Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds Conservative Scenario: Slow adoption, regulatory delays, economic constraints Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption
Tyler W
If additional glycaemic control is needed after at least 30 days, the dose may be increased to 14 mg once daily
Peptide-1 Agonist Relieves IBS Pain but Raises Side Effects The following is a summary of Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis, published in the March 2025 issue of Frontiers in Endocrinology by Mostafa and Alrasheed
US$ 23.89
US$ 26.13
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
US$ 26.73
